CE-certified Korean dermal fillers containing 20mg/ml high-density cross-linked HA with 0.3% lidocaine. Provides 1-3 year longevity through patented stabilization technology. FDA-equivalent manufacturing standards ensure 98.7% purity for facial volumization and nonsurgical body contouring.

▲ Key Clinical Advantages

▲ Dual-Viscosity Technology

▲ Professional Packaging

◈ 10ml sterile syringe
◈ Luer-lock cannula compatible
◈ Batch-tracked production
◈ Temperature-controlled shipping

▲ Injection Protocol

1. Administer in deep subcutaneous layer
2. Maintain 26G+ needle size
3. Maximum 2ml per site session
4. Post-treatment cold compression advised

*For licensed practitioners only. Not for IV/IM use. Contraindicated for patients with autoimmune disorders or active skin infections. Post-market surveillance data shows <0.01% nodule formation rate when properly administered.Results may vary based on individual biochemistry and treatment compliance.